Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Gemcitabine × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Pancreatic Neoplasms 17 Urinary Bladder Neoplasms 14 Lung Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 9 Colorectal Neoplasms 9 Ovarian Neoplasms 7 Non-Muscle Invasive Bladder Neoplasms 7 Biliary Tract Neoplasms 7 Neoplasm Metastasis 6 Nasopharyngeal Carcinoma 6 Uterine Cervical Neoplasms 4 Gallbladder Neoplasms 4 Fallopian Tube Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Pancreatic Ductal 4 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasms 3 Hodgkin Disease 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Transitional Cell 3 Breast Neoplasms 3 Sarcoma 2 Recurrence 2 Osteosarcoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2

Interventions

Nivolumab 16 Magnetic Resonance Spectroscopy 15 pembrolizumab 14 cabozantinib 12 Specimen Handling 12 Ipilimumab 10 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 aldesleukin 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 spartalizumab 2 belzutifan 2 avelumab 2 aflibercept 2 X-Rays 2 Watchful Waiting 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1 tivozanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡